Newly Split Celera and ABI Settle on Terms for Sharing Tech and IP, Divvy Up Dx Market | GenomeWeb
NEW YORK (GenomeWeb News) – Applied Biosystems and Celera may have split into two independently operated companies on July 1, but they will continue to share certain instruments, technologies, and intellectual property, according to documents filed today with the US Securities and Exchange Commission.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.